Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Diabetes insipidus followed, after 4 years, with dysarthria and mild right-sided hemiparesis--the first clinical signs of Erdheim-Chester disease. Description and depiction of a case with a review of information on the disease].
Adam Z, Balsíková K, Pour L, Krejcí M, Svacina P, Dufek M, Kren L, Hermanová M, Moulis M, Vanícek J, Neubauer J, Mechl M, Prásek J, Stanícek J, Koukalová R, Hájek R, Mayer J. Adam Z, et al. Among authors: moulis m. Vnitr Lek. 2009 Dec;55(12):1173-88. Vnitr Lek. 2009. PMID: 20070034 Review. Czech.
[Partial regression of CNS lesions of Erdheim-Chester disease after treatment with 2-chlorodeoxadenosine and their full remission following treatment with lenalidomide].
Adam Z, Sprláková A, Rehák Z, Koukalová R, Szturz P, Krejcí M, Pour L, Zahradová L, Cervinek L, Kren L, Moulis M, Hermanová M, Mechl M, Prásek J, Hájek R, Král Z, Mayer J. Adam Z, et al. Among authors: moulis m. Klin Onkol. 2011;24(5):367-81. Klin Onkol. 2011. PMID: 22070019 Czech.
[Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z, Rehák Z, Koukalová R, Szturz P, Krejčí M, Pour L, Zahradová L, Moulis M, Kodet R, Nebeský T, Brejcha M, Adamová Z, Hájek R, Mayer J. Adam Z, et al. Among authors: moulis m. Vnitr Lek. 2012 Jan;58(1):62-71. Vnitr Lek. 2012. PMID: 22448704 Czech.
[Treatment of AL-amyloidosis--results from one clinic and review of published experience with new agents (bortezomib, thalidomide and lenalidomide) in AL-amyloidosis].
Adam Z, Pour L, Krejcí M, Zahradová L, Krivanová A, Mardová J, Kovárová L, Stepánková S, Moulis M, Kren L, Veselý K, Svobodová I, Germáková Z, Nedbálková M, Mayer J, Hájek R. Adam Z, et al. Among authors: moulis m. Vnitr Lek. 2010 Mar;56(3):190-209. Vnitr Lek. 2010. PMID: 20394205 Review. Czech.
[Castleman disease].
Szturz P, Moulis M, Adam Z, Slaisová R, Koukalová R, Rehák Z, Volfová P, Hájek R, Mayer J. Szturz P, et al. Among authors: moulis m. Klin Onkol. 2011;24(6):424-34. Klin Onkol. 2011. PMID: 22257231 Review. Czech.
66 results